Silica/Annona muricata nano-hybrid: Synthesis and anticancer activity against breast cancer.
Ontology highlight
ABSTRACT: Biogenically derived silica nanoparticles may serve as a well-defined target vehicle for drug delivery and have a wide range of applications in biomedicine. Silica nanoparticles are an excellent candidate as drug carriers due to their mesoporous structure, high drug loading capacity, low toxicity, environmental friendliness and low economic synthesis procedures. In this study, nano structured silica was extracted from sugarcane bagasse through an alkali leaching extraction and conjugated with A. muricata extract overcoming its poor solubility and improving its bioavailability within the host system. The Silica Nanoparticles (SNP) and Annona muricata conjugated Silica Nanoparticles (AM/SNP) were characterized using SEM, FTIR, TGA, EDAX, XRD and zeta potential. The AM/SNP was subjecte
SUBMITTER: Perinbarajan GK
PROVIDER: S-EPMC10844132 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA